|
US3705185A
(en)
|
1969-04-14 |
1972-12-05 |
Minnesota Mining & Mfg |
N-aroyl sulfonamides
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
EP0102324A3
(de)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipide und Tenside in wässriger Phase
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
GB8524157D0
(en)
|
1984-10-19 |
1985-11-06 |
Ici America Inc |
Heterocyclic amides
|
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
DK24089D0
(da)
|
1989-01-20 |
1989-01-20 |
Hans Bundgaard |
Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups
|
|
GB8911854D0
(en)
|
1989-05-23 |
1989-07-12 |
Ici Plc |
Heterocyclic compounds
|
|
US5112596A
(en)
|
1990-04-23 |
1992-05-12 |
Alkermes, Inc. |
Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability
|
|
US5268164A
(en)
|
1990-04-23 |
1993-12-07 |
Alkermes, Inc. |
Increasing blood-brain barrier permeability with permeabilizer peptides
|
|
IL101860A0
(en)
|
1991-05-31 |
1992-12-30 |
Ici Plc |
Heterocyclic derivatives
|
|
EP0567997A1
(de)
|
1992-04-30 |
1993-11-03 |
Hoechst Aktiengesellschaft |
4- oder 5-(Sulf)imido- und (Sulfon)amidopyridine, sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
ATE191853T1
(de)
|
1992-07-27 |
2000-05-15 |
Us Health |
Zielgerichte liposome zur blut-hirne schranke
|
|
ES2187518T3
(es)
|
1992-11-23 |
2003-06-16 |
Aventis Pharma Inc |
3-(aminoalquilamino)-1-2-benzisoxazoles sustituidos y compuestos relacionados.
|
|
US5573653A
(en)
|
1994-07-11 |
1996-11-12 |
Sandoz Ltd. |
Electrochemical process for thiocyanating aminobenzene compounds
|
|
GB9514160D0
(en)
*
|
1994-07-25 |
1995-09-13 |
Zeneca Ltd |
Aromatic compounds
|
|
ES2208690T3
(es)
|
1994-08-30 |
2004-06-16 |
Sankyo Company Limited |
Isoxazol.
|
|
US5753653A
(en)
|
1995-12-08 |
1998-05-19 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
GB9828442D0
(en)
|
1998-12-24 |
1999-02-17 |
Karobio Ab |
Novel thyroid receptor ligands and method II
|
|
JP4316787B2
(ja)
|
2000-01-11 |
2009-08-19 |
壽製薬株式会社 |
エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、
|
|
US6514221B2
(en)
|
2000-07-27 |
2003-02-04 |
Brigham And Women's Hospital, Inc. |
Blood-brain barrier opening
|
|
AU2001286557A1
(en)
*
|
2000-08-23 |
2002-03-04 |
Merck Frosst Canada And Co. |
Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists
|
|
US20020065259A1
(en)
|
2000-08-30 |
2002-05-30 |
Schatzberg Alan F. |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
US7034036B2
(en)
|
2000-10-30 |
2006-04-25 |
Pain Therapeutics, Inc. |
Inhibitors of ABC drug transporters at the blood-brain barrier
|
|
DE10121982B4
(de)
|
2001-05-05 |
2008-01-24 |
Lts Lohmann Therapie-Systeme Ag |
Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung
|
|
AU2002322720B2
(en)
|
2001-07-25 |
2008-11-13 |
Raptor Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
|
KR100789567B1
(ko)
|
2001-11-06 |
2007-12-28 |
동화약품공업주식회사 |
3-아미도-1,2-벤조이소옥사졸 유도체, 그 염, 제조방법 및 용도
|
|
DE10201550A1
(de)
|
2002-01-17 |
2003-07-31 |
Merck Patent Gmbh |
Phenoxy-Piperidine
|
|
US20030162695A1
(en)
|
2002-02-27 |
2003-08-28 |
Schatzberg Alan F. |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
US7332486B2
(en)
|
2002-08-08 |
2008-02-19 |
Memory Pharmaceuticals Corp. |
Phosphodiesterase 4 inhibitors
|
|
JP4995423B2
(ja)
|
2002-12-03 |
2012-08-08 |
ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート |
物質を血液−脳関門を渡って輸送するための人工低密度リポタンパク質キャリア
|
|
MY141521A
(en)
|
2002-12-12 |
2010-05-14 |
Hoffmann La Roche |
5-substituted-six-membered heteroaromatic glucokinase activators
|
|
GT200300283A
(es)
*
|
2002-12-12 |
2004-07-14 |
|
Activadores de glucoquinasa heteroaromaticos de seis miembros 5-sustituidos
|
|
AP2005003418A0
(en)
|
2003-04-15 |
2005-12-31 |
Pfizer |
Alpha substituted carboxylic acids as ppar modulators.
|
|
CN1863785A
(zh)
|
2003-08-08 |
2006-11-15 |
沃泰克斯药物股份有限公司 |
在疼痛的治疗中用作钠或钙通道阻断剂的杂芳基氨基磺酰基苯基衍生物
|
|
EP1673357A2
(en)
|
2003-08-08 |
2006-06-28 |
Vertex Pharmaceuticals Incorporated |
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
|
|
JP2007505142A
(ja)
|
2003-09-10 |
2007-03-08 |
セダーズ−シナイ メディカル センター |
血液脳関門を通過する薬剤のカリウムチャネル媒介性送達
|
|
ES2334795T3
(es)
|
2003-10-03 |
2010-03-16 |
Portola Pharmaceuticals, Inc. |
Sulfonilureas 2,4-dioxo-3-quinazolinilarilo.
|
|
US7081539B2
(en)
|
2004-03-25 |
2006-07-25 |
Dainippon Sumitomo Pharma Co., Ltd. |
One-pot process for the preparation of 1,2-benzisoxazole-3-methanesulfonamide
|
|
MY134672A
(en)
|
2004-05-20 |
2007-12-31 |
Japan Tobacco Inc |
Stable crystal of 4-oxoquinoline compound
|
|
US20080312286A1
(en)
|
2004-07-30 |
2008-12-18 |
Pinkerton Anthony B |
Indanone Potentiators of Metabotropic Glutamate Receptors
|
|
WO2006020830A2
(en)
|
2004-08-12 |
2006-02-23 |
Amgen Inc. |
Bisaryl-sulfonamides
|
|
EP1812429A4
(en)
|
2004-09-29 |
2010-07-21 |
Portola Pharm Inc |
SUBSTITUTED 2H-1,3-BENZOXAZIN-4 (3H) -ONE
|
|
JP2008189549A
(ja)
|
2005-05-12 |
2008-08-21 |
Astellas Pharma Inc |
カルボン酸誘導体またはその塩
|
|
DE102005038947A1
(de)
|
2005-05-18 |
2006-11-30 |
Grünenthal GmbH |
Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
CN101277939A
(zh)
|
2005-09-09 |
2008-10-01 |
布里斯托尔-迈尔斯斯奎布公司 |
无环ikur抑制剂
|
|
CA2625039A1
(en)
|
2005-10-19 |
2007-04-26 |
F. Hoffmann-La Roche Ag |
N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors
|
|
CA2630234A1
(en)
|
2005-11-23 |
2007-05-31 |
Ligand Pharmaceuticals Inc. |
Thrombopoietin activity modulating compounds and methods
|
|
AR058296A1
(es)
|
2005-12-09 |
2008-01-30 |
Kalypsys Inc |
Inhibidores de histona desacetilasa y composicion farmaceutica
|
|
EP2004596A2
(en)
|
2006-04-11 |
2008-12-24 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of voltage-gated sodium channels
|
|
WO2008045393A2
(en)
|
2006-10-11 |
2008-04-17 |
Amgen Inc. |
Imidazo- and triazolo-pyridine compounds and methods of use therof
|
|
CA2676665A1
(en)
|
2007-01-30 |
2008-08-07 |
Biogen Idec Ma Inc. |
Modulators of mitotic kinases
|
|
AU2008213836A1
(en)
*
|
2007-02-05 |
2008-08-14 |
Xenon Pharmaceuticals Inc. |
Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions
|
|
EP1995241B1
(en)
|
2007-03-23 |
2010-03-17 |
ICAgen, Inc. |
Inhibitors of ion channels
|
|
MX2009012678A
(es)
|
2007-05-25 |
2012-09-20 |
Vertex Pharma |
Moduladores de canal de ion y metodos de uso.
|
|
US20100179137A1
(en)
*
|
2007-06-07 |
2010-07-15 |
Takashi Kamikubo |
Pyridone compound
|
|
US20090012103A1
(en)
|
2007-07-05 |
2009-01-08 |
Matthew Abelman |
Substituted heterocyclic compounds
|
|
WO2009010784A1
(en)
|
2007-07-13 |
2009-01-22 |
Astrazeneca Ab |
New compounds 955
|
|
US8124610B2
(en)
|
2007-07-13 |
2012-02-28 |
Icagen Inc. |
Sodium channel inhibitors
|
|
US20110092703A1
(en)
|
2007-08-10 |
2011-04-21 |
Nippon Chemiphar Co., Ltd. |
P2x4 receptor antagonist
|
|
GB0720390D0
(en)
|
2007-10-18 |
2007-11-28 |
Prosidion Ltd |
G-Protein coupled receptor agonists
|
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
EP2565191B1
(en)
*
|
2008-05-14 |
2014-10-08 |
Astellas Pharma Inc. |
4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy
|
|
JP5304785B2
(ja)
|
2008-06-23 |
2013-10-02 |
アステラス製薬株式会社 |
スルホンアミド化合物又はその塩
|
|
WO2010022055A2
(en)
|
2008-08-20 |
2010-02-25 |
Amgen Inc. |
Inhibitors of voltage-gated sodium channels
|
|
PE20120008A1
(es)
|
2009-01-12 |
2012-01-24 |
Icagen Inc |
Derivados de fenoxi bencenosulfonamida
|
|
ES2642586T3
(es)
|
2009-07-27 |
2017-11-16 |
Gilead Sciences, Inc. |
Compuestos heterocíclicos condensados como moduladores de canales iónicos
|
|
WO2011016234A1
(en)
|
2009-08-04 |
2011-02-10 |
Raqualia Pharma Inc. |
Picolinamide derivatives as ttx-s blockers
|
|
KR101678255B1
(ko)
*
|
2009-09-25 |
2016-11-21 |
아스텔라스세이야쿠 가부시키가이샤 |
치환 아미드 화합물
|
|
WO2011059042A1
(ja)
|
2009-11-12 |
2011-05-19 |
武田薬品工業株式会社 |
芳香環化合物
|
|
WO2011063001A1
(en)
|
2009-11-18 |
2011-05-26 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
|
TW201139406A
(en)
|
2010-01-14 |
2011-11-16 |
Glaxo Group Ltd |
Voltage-gated sodium channel blockers
|
|
HUE029012T2
(en)
|
2010-02-12 |
2017-02-28 |
Nivalis Therapeutics Inc |
New S-nitrosoglutathion reductase inhibitors
|
|
WO2011153588A1
(en)
|
2010-06-10 |
2011-12-15 |
Biota Scientific Management Pty Ltd |
Viral polymerase inhibitors
|
|
US20120004714A1
(en)
|
2010-06-30 |
2012-01-05 |
Ryan Kleve |
Lead having coil electrode with preferential bending region
|
|
US9279003B2
(en)
|
2010-07-07 |
2016-03-08 |
Purdue Pharma L.P. |
Analogs of sodium channel peptide toxin
|
|
ES2526675T3
(es)
|
2010-07-09 |
2015-01-14 |
Pfizer Limited |
N-sulfonilbenzamidas como inhibidores de los canales de sodio dependientes de voltaje
|
|
JP5872552B2
(ja)
|
2010-07-09 |
2016-03-01 |
ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ |
化学化合物
|
|
CA2804593C
(en)
|
2010-07-09 |
2015-11-24 |
Pfizer Limited |
Biphenyloxybenzensulphonamide derivatives useful as sodium channel inhibitors
|
|
JP2013531030A
(ja)
|
2010-07-12 |
2013-08-01 |
ファイザー・リミテッド |
電位開口型ナトリウムチャネルの阻害剤としてのｎ−スルホニルベンズアミド
|
|
JP2013532184A
(ja)
*
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
電位開口型ナトリウムチャネル阻害剤として有用なｎ−スルホニルベンズアミド誘導体
|
|
CA2804351A1
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Chemical compounds
|
|
JP2013532185A
(ja)
|
2010-07-12 |
2013-08-15 |
ファイザー・リミテッド |
化合物
|
|
JP2013536165A
(ja)
|
2010-07-12 |
2013-09-19 |
ファイザー・リミテッド |
痛みの処置のためのｎａｖ１．７阻害薬としてのスルホンアミド誘導体
|
|
JP2013531687A
(ja)
|
2010-07-16 |
2013-08-08 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
ナトリウムチャネル遮断剤としてのピリジン化合物
|
|
PT2616465E
(pt)
|
2010-09-13 |
2016-03-09 |
Novartis Ag |
Triazino-oxadiazoles
|
|
WO2012039657A1
(en)
|
2010-09-22 |
2012-03-29 |
Astrazeneca Ab |
Novel chromane compound for the treatment of pain disorders
|
|
EP2655330B1
(en)
|
2010-12-22 |
2016-02-10 |
Purdue Pharma LP |
Substituted pyridines as sodium channel blockers
|
|
WO2012095781A1
(en)
|
2011-01-13 |
2012-07-19 |
Pfizer Limited |
Indazole derivatives as sodium channel inhibitors
|
|
KR101923367B1
(ko)
|
2011-02-02 |
2018-12-04 |
버텍스 파마슈티칼스 인코포레이티드 |
이온 채널의 조절제로서의 피롤로피라진―스피로사이클릭 피페리딘 아미드
|
|
MX2014001851A
(es)
|
2011-08-17 |
2014-10-24 |
Amgen Inc |
Inhibidores del canal de heteroarilo sodio.
|
|
WO2013056232A2
(en)
|
2011-10-13 |
2013-04-18 |
Case Western Reserve University |
Rxr agonists compounds and methods
|
|
IN2014CN02959A
(https=)
|
2011-10-28 |
2015-07-03 |
Merck Sharp & Dohme |
|
|
JP6014155B2
(ja)
|
2011-10-31 |
2016-10-25 |
ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
ビアリールエーテルスルホンアミドおよび治療剤としてのそれらの使用
|
|
US9630929B2
(en)
|
2011-10-31 |
2017-04-25 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
|
US9133131B2
(en)
|
2011-11-15 |
2015-09-15 |
Purdue Pharma L.P. |
Pyrimidine diol amides as sodium channel blockers
|
|
US9012443B2
(en)
|
2011-12-07 |
2015-04-21 |
Amgen Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
|
WO2013088315A1
(en)
*
|
2011-12-15 |
2013-06-20 |
Pfizer Limited |
Sulfonamide derivatives
|
|
US20150291514A1
(en)
*
|
2012-01-04 |
2015-10-15 |
Pfizer Limted |
N-Aminosulfonyl Benzamides
|
|
JP2015083542A
(ja)
|
2012-02-08 |
2015-04-30 |
大日本住友製薬株式会社 |
３位置換プロリン誘導体
|
|
US8889741B2
(en)
|
2012-02-09 |
2014-11-18 |
Daiichi Sankyo Company, Limited |
Cycloalkane derivatives
|
|
WO2013122897A1
(en)
|
2012-02-13 |
2013-08-22 |
Amgen Inc. |
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
|
|
WO2013134518A1
(en)
|
2012-03-09 |
2013-09-12 |
Amgen Inc. |
Sulfamide sodium channel inhibitors
|
|
WO2013146969A1
(ja)
|
2012-03-29 |
2013-10-03 |
第一三共株式会社 |
新規二置換シクロヘキサン誘導体
|
|
SG11201408284VA
(en)
|
2012-05-22 |
2015-02-27 |
Xenon Pharmaceuticals Inc |
N-substituted benzamides and their use in the treatment of pain
|
|
US10071957B2
(en)
|
2012-07-06 |
2018-09-11 |
Genentech, Inc. |
N-substituted benzamides and methods of use thereof
|
|
CN104640843A
(zh)
|
2012-07-19 |
2015-05-20 |
大日本住友制药株式会社 |
1-(环烷基羰基)脯氨酸衍生物
|
|
US9388179B2
(en)
|
2012-10-26 |
2016-07-12 |
Merck Sharp & Dohme Corp. |
N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
CA2889378A1
(en)
|
2012-10-26 |
2014-05-01 |
Merck Sharp & Dohme Corp. |
Benzoxazolinone compounds with selective activity in voltage-gated sodium channels
|
|
EP2935257B1
(en)
|
2012-12-20 |
2018-02-07 |
Purdue Pharma LP |
Cyclic sulfonamides as sodium channel blockers
|
|
RS56015B1
(sr)
|
2013-01-31 |
2017-09-29 |
Vertex Pharma |
Piridon amidi kao modulatori natrijumovih kanala
|
|
US20140296266A1
(en)
|
2013-03-01 |
2014-10-02 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
US9550775B2
(en)
|
2013-03-14 |
2017-01-24 |
Genentech, Inc. |
Substituted triazolopyridines and methods of use thereof
|
|
ES2687481T3
(es)
|
2013-03-15 |
2018-10-25 |
Chromocell Corporation |
Moduladores del canal de sodio para el tratamiento del dolor
|
|
MX2015010775A
(es)
|
2013-03-15 |
2016-04-25 |
Genentech Inc |
Benzoxazoles sustituidos y metodos para usarlos.
|
|
US9663508B2
(en)
|
2013-10-01 |
2017-05-30 |
Amgen Inc. |
Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
|
|
CR20160296A
(es)
|
2013-11-27 |
2016-09-20 |
Genentech Inc |
Benzamidas sustituidas y métodos para usarlas
|